share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
美股sec公告 ·  06/04 16:35
Moomoo AI 已提取核心訊息
On June 3, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. On the same day, he sold 11,625 shares in an open market transaction at a price of $10.2972 per share, resulting in a total market value of $119,704.95 for the disposed shares. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 3,700 shares.
On June 3, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. On the same day, he sold 11,625 shares in an open market transaction at a price of $10.2972 per share, resulting in a total market value of $119,704.95 for the disposed shares. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 3,700 shares.
2024年6月3日,與eyepoint pharmaceuticals有關的David R. Guyer完成了一系列涉及公司普通股的交易。Guyer通過行使或轉換衍生證券,以每股3.26美元至3.50美元的價格獲得總共9,775股股票。在同一天,Guyer通過公開市場交易以每股10.2972美元的價格出售了11,625股股票,導致處置股票的總市值為119,704.95美元。在這些交易之後,Guyer在eyepoint pharmaceuticals的直接持股減少到3,700股。
2024年6月3日,與eyepoint pharmaceuticals有關的David R. Guyer完成了一系列涉及公司普通股的交易。Guyer通過行使或轉換衍生證券,以每股3.26美元至3.50美元的價格獲得總共9,775股股票。在同一天,Guyer通過公開市場交易以每股10.2972美元的價格出售了11,625股股票,導致處置股票的總市值為119,704.95美元。在這些交易之後,Guyer在eyepoint pharmaceuticals的直接持股減少到3,700股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息